Infusystems Holdings, Inc. · AMEX:INFU
Infusystems — InfuSystem Holdings — Investor Presentation (April 2015)
19 slides from Infusystems's investor presentation, Apr 17, 2015
Slide 1: InfuSystem Holdings, Inc. Shareholder Presentation
InfuSystem Holdings, Inc. Shareholder Presentation As of April 15, 2015 Eric Steen – CEO Jonathan Foster – CFO
Slide 2: Safe Harbor Statement
Safe Harbor Statement Certain statements contained in this presentation are forward?looking statements and are based on future expectations, plans and prospects for the business and operations of InfuSystem Holdings, Inc. (“InfuSystem” or “the Company”) that involve a number of risks and uncertainti
Slide 3: Summary
Summary InfuSystem is a growing healthcare company that provides infusion pumps and related products and services for patients in the home, in oncology clinics, ambulatory surgery centers, and other sites of care from five locations serving all 50 States and Canada. We deliver improved patient satis
Slide 4: Company Overview
InfuSystem ?“Infusion Made Easy” Company Overview Fiscal Year Dec 31, 2014 Provides infusion pumps and related Revenues $66.5M (Up 7%) products and services for patients in: AEBITDA $16.1M (Up 1%) The Patient’s Home Market Cap $66.3M @ $2.95 Oncology Clinics Ambulatory Surgery Centers (as of 4/13/15
Slide 5: Revenue Streams
InfuSystem Revenue Streams Sales & Rental revenue Insurance via 3 Company acturer, revenue InfuSystem Rental Companies streams. InfuSystem Clinic Patient Co-pay & Clinic, Hospital, Deductible InfuSystem Home Infusion Patient
Slide 6: Revenue Diversification
Revenue Diversification 2009 Revenues $39M 2014 Revenues 1% 2% 12% 1% 3% 26% 12% 70% 49% 23% Rentals ? Colorectal Cancer Rentals ? Other Cancers Rentals ? Infectious Disease Rentals ? Pain Management Rentals ? Hospitals/Home Care Rentals ? Service & Repair Sales ? Equip, Consumables
Slide 7: Provider Niche – Therapy Started in Clinic
InfuSystem Provider Niche – Therapy Started in Clinic Chemotherapy at Home Nerve Block at Home InfuSystem is the market 5.69M orthopedic leader with over 1,600 surgeries annually practice sites served 50% are projected to be Total Estimated over $200 M Continuous Peripheral market. Nerve Block Candi
Slide 8: Electronic Connectivity
Electronic Connectivity through Electronic Medical Record (EMR) Interface Electronic Data Exchange Interface Effects Fuels market share gains Efficiency advantage vs smaller players Greater revenue per employee Greater customer satisfaction
Slide 9: Lifecycle Management – Infusion Pumps
Lifecycle Management – Infusion Pumps Total Pump Fleet Management • Online, Anytime • Order New Pumps • Schedule Service & Repair • Access Recertification Docs
Slide 10: Lifecycle Management – Asset Tracking
Lifecycle Management – Asset Tracking Smart Metrics Loss Threat Count 11 Loss Threat Percent 3% Assets Under Par 7 30 Day Average Daily Check?Outs 6
Slide 11: High Patient Satisfaction Scores
High Patient Satisfaction Scores
Slide 12: For Faster Turnaround and Improved Utilization
For Faster Turnaround and Improved Utilization InfuSystem Distribution Reduced cost of air Toronto Canada shipments Service Center Improved Madison Heights utilization of pumps Service Center Increased market Kansas City share of same?day Service Center Future Northeast rental market Los Angeles Are
Slide 13: New Products & Services
New Products & Services Pain Management Service Catheter care kits Pole?mounted pump sales and rentals in oncology Smart Pump Services Infusion disposals including IV administration sets & chemo safety
Slide 14: Financial Overview
2015 vs 2014: Increase in G&A expense on IT and Financial Overview Pain Management initiatives of $0.7 million; a write-off of pumps of $0.4 million, severance of $0.2 million. Revenues Adjusted EBITDA (1) $70m $66,487 $18m Revenues $16,062 $62,280 $15,962 Growing $58,828 $60m AEBITDA $54,637 $14m G
Slide 15: Uses of Free Cash Flow
Uses of Free Cash Flow Total Debt PP&E and Medical Equipment in Service (at cost) $35m $46m Debt $43.1 $32.2 $44m $31.3 Declining Rental Fleet $42m Increasing $40.9 $30m $29.1 $39.5 $28.5 $28.3 $40m $27.6 $27.2 $27.9 $38.5 $26.7 $26.7 $37.0 $37.2 $25.5 $38m $35.0 $35.5 $24.1 $36m $25m $34.2 $34m $32
Slide 16: New $45 Million Credit Facility
New $45 Million Credit Facility • $45 million credit facility signed with JPMorgan Chase • Term is five years • $10 million revolver – undrawn at close • $27 million Term A Loan – fully drawn at close • $8 million Term B Loan – undrawn drawn at close • Expansion capital • Interest rate drops from 7.
Slide 17: Positioned For Growth
Positioned For Growth Market Trends Leadership Strategy •InfuSystem is uniquely •Experienced Medical •Increased use of electronic positioned to take efficient Industry Executives connectivity advantage of growing •Focused on improving •Expanding geographic market trends in… patient satisfaction and
Slide 18: Where Does This Take INFU?
Where Does This Take INFU? Aging Population and Cancer Growth More Patients Home IV , Commercial Pay Recognizing Value, CMS Competitive Bidding Peripheral Nerve Block and Smart Pump Growth Revenue Growth in High Single Digits Through 2015
Slide 19: Thank You
Thank You for Your Interest! IR Contact Info: Joe Dorame Managing Partner Lytham Partners, LLC 602?889?9700 dorame@lythampartners.com
InfuSystem Holdings — Investor Presentation (April 2015) on 6ix